Back to results
US 2006/0142237 A1Published application
Method for treatment of multiple sclerosis
AssigneeCan-Fite Biopharma Ltd.
InventorsPnina Fishman, Sara Bar Yehuda, Lea Madi
Life of this patent
Estimating the term…
Abstract
Use of an A3 adenosine receptor agonist in the preparation of a pharmaceutical composition for the treatment of an individual suffering from multiple sclerosis. The composition is preferably orally administered. Also disclosed is a pharmaceutical composition for the treatment of multiple sclerosis that comprises an effective amount of an A3 adenosine receptor agonist and a pharmaceutically acceptable carrier.
Claims6
1-10. (canceled)
A method for treating an individual suffering from multiple sclerosis (MS) comprising administrating to said individual an A3 adenosine receptor agonist (A3RAg).
Dependencies are inferred from the claim text.